| Chelidonine quaternary ammonium reaction product with thiotepa was subjected to a number of pharmacological tests including anticancer activity. These quaternized alkaloids were claimed for use in the treatment of immunological or metabolic dysfunction, cancer, bacterial, fungal and viral infections, radiation damage, epilepsy, multiple sclerosis, skin diseases, postoperative wounds, pain, sleeping disease, herpes infections, influenza virus infections, skin tumors, allergies, chronic fatigue syndrome, osteoporosis, rheumatic diseases, and scars. |
